Treatment Outcome of MDR/RR TB in a Resource-Constrained Setup: A Four-Year Retrospective Analysis

References

• World Health Oraganiztion. Antimicrobial resistance [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed August 15, 2022.
   Google Scholar
• World Health Organization. Global tuberculosis report 2021 [Internet]. Geneva: World Health Organization; 2021. Available from: https://www.who.int/publications-detail-redirect/9789240037021. Accessed August 15, 2022.
   Google Scholar
• Mirzayev F, Viney K, Linh NN, et al. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. Eur Respir J. 2021;57(6):2003300. doi:10.1183/13993003.03300-2020
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report 2020 [Internet]. Geneva: World Health Organization; 2020. Available from: https://www.who.int/publications-detail-redirect/9789240013131. Accessed August 15, 2022.
   Google Scholar
• FMoH. National strategic plan tuberculosis and leprosy control 2006 – 2013 EC (2013/14 – 2020); 2017.
   Google Scholar
• Bogale L, Tsegaye T, Abdulkadir M, Akalu TY. Unfavorable treatment outcome and its predictors among patients with multidrug-resistance tuberculosis in Southern Ethiopia in 2014 to 2019: a multi-center retrospective follow-up study. Infect Drug Resist. 2021;14:1343–1355. doi:10.2147/IDR.S300814
   PubMed Web of Science ®Google Scholar
• Khatri U. Quality of Tuberculosis Services Assessment in Ethiopia. Chapel Hill, NC, USA: University of North Carolina; 2020.
   Google Scholar
• FMoH. Guidelines on programmatic management of drug resistant tuberculosis in Ethiopia; 2013.
   Google Scholar
• Nandini S, Ashwani K, Shivani C, et al. Trends & treatment outcomes of multidrug-resistant tuberculosis in Delhi, India (2009–2014): a retrospective record-based study. Indian J Med Res. 2020;151(6):598–603. doi:10.4103/ijmr.IJMR_1048_18
   Web of Science ®Google Scholar
• Pagana KD, Pagana TJ, Pagana TN. Mosby’s Diagnostic & Laboratory Test Reference. 14th ed. St. Louis, Mo: Elsevier; 2019.
   Google Scholar
• Chen Y, Yuan Z, Shen X, Wu J, Wu Z, Xu B. Time to multidrug-resistant tuberculosis treatment initiation in association with treatment outcomes in Shanghai, China. Antimicrob Agents Chemother. 2018;62(4):e02259–17. doi:10.1128/AAC.02259-17
   Web of Science ®Google Scholar
• World Health Organization. World Health Organization Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance Andresponse. Geneva, Switzerland. Geneva Switz: WorldHealthOrganization; 2010.
   Google Scholar
• Meressa D, Hurtado RM, Andrews JR, et al. Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia—an observational cohort study. Thorax. 2015;70(12):1181–1188. doi:10.1136/thoraxjnl-2015-207374
   PubMed Web of Science ®Google Scholar
• Gandhi NR, Shah NS, Andrews JR, et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010;181(1):80–86. doi:10.1164/rccm.200907-0989OC
   PubMed Web of Science ®Google Scholar
• Patel SV, Nimavat KB, Alpesh PB, et al. Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: a prospective study. J Infect Public Health. 2016;9(4):478–484. doi:10.1016/j.jiph.2015.11.011
   PubMed Web of Science ®Google Scholar
• Helbling P, Altpeter E, Egger JM, Zellweger JP. Treatment outcomes of multidrug-resistant tuberculosis in Switzerland. Swiss Med Wkly; 2014 Available from: https://smw.ch/article/doi/smw.2014.14053. Accessed August 15, 2022.
   Google Scholar
• Anderson LF, Tamne S, Watson JP, et al. Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Eurosurveillance. 2013;18(40):20601. doi:10.2807/1560-7917.ES2013.18.40.20601
   Web of Science ®Google Scholar
• Marks SM, Flood J, Seaworth B, et al. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005–2007. Emerg Infect Dis. 2014;20(5):812–821. doi:10.3201/eid2005.131037
   PubMed Web of Science ®Google Scholar
• FMoH. Training material on programmatic management of drug resistant tuberculosis in Ethiopia for GHWs facilitators’ guide; 2012.
   Google Scholar
• Giovanni Battista M, Dheda K, Centis R, et al. Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa. Trop Med Int Health. 2010;15(9):1052–1066. doi:10.1111/j.1365-3156.2010.02581.x
   Web of Science ®Google Scholar
• Marais E, Mlambo CK, Lewis JJ, et al. Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa. Infection. 2014;42(2):405–413. doi:10.1007/s15010-013-0572-2
   Web of Science ®Google Scholar
• Gandhi NR, Andrews JR, Brust JCM, et al. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2012;16(1):90–97. doi:10.5588/ijtld.11.0153
   Web of Science ®Google Scholar
• Kurbatova EV, Taylor A, Gammino VM, et al. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis. 2012;92(5):397–403. doi:10.1016/j.tube.2012.06.003
   PubMed Web of Science ®Google Scholar
• Satti H, McLaughlin MM, Hedt-Gauthier B, et al. Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho. PLoS One. 2012;7(10):e46943. doi:10.1371/journal.pone.0046943
   PubMed Web of Science ®Google Scholar
• Kassa GM, Tadesse A, Gelaw YA, et al. Predictors of mortality among multidrug-resistant tuberculosis patients in central Ethiopia: a retrospective follow-up study. Epidemiol Infect. 2020;148. doi:10.1017/S0950268820002514
   Web of Science ®Google Scholar
• Ayinalem A, Bitew ZW, Worku T. Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in Ethiopia: a systematic review and meta-analysis. Int J Infect Dis. 2020;1(98):420–439.
   Google Scholar
• World Health Organization. Rapid Communication: Key Changes to the Treatment of Drug-Resistant Tuberculosis. World Health Organization; 2022.
   Google Scholar